Katrina Pollock

RECOVERY pre-print out. In hypoxic hospitalised COVID-19 patients requiring either no oxygen or simple oxygen only, higher dose corticosteroids significantly increased the risk of death compared to usual care, which included low dose corticosteroids.medrxiv.org/content/10.110…

This has been an excellent collaboration with new insights into immunogenicity of #COVID-19 vaccines in inflammatory bowel disease sciencedirect.com/science/articl…

Ebola outbreak in Uganda: how worried are researchers? nature.com/articles/d4158…

Implementation of covid-19 vaccination in the United Kingdom | The BMJ bmj.com/content/378/bm…

A midweek night out with an educational twist. Fast paced and fun evening at the #pride Lates | Science Museum with ⁦@robin_shattock⁩ talking about #HIV #vaccines for ⁦@eavi2020⁩ sciencemuseum.org.uk/see-and-do/lat…

Brilliant day out for the LEGACY Network at the Great Exhibition Road Festival on ancestry, #vaccines and lymph nodes. Great job colouring! ⁦@britsocimm⁩ ⁦@ImperialMed⁩ ⁦@ImperialInfect⁩

Excellent primer from ⁦⁦@ajpollard1⁩ A guide to vaccinology: from basic principles to new developments | Nature Reviews Immunology nature.com/articles/s4157…

What’s next for an HIV #vaccine? After two days of exciting science at the #EAVI2020 meeting @robin_shattock explains why our innovative experimental medicine studies are needed to meet the challenge of developing an effective #HIV vaccine

I know that almost no-one in the UK wants to hear this, but the number of people being hospitalised who are +ve for COVID is increasing again (before anyone asks - we are seeing people admitted because of COVID, & not just incidental cases) 1/6

And to round off #InternationalWomensDay2022, Dr Katrina Pollock (@DrKatPollock) of @imperialcollege takes the opportunity to celebrate all the contributions made my women to the important vaccine research that has secured a brighter future for us all 💉 #BreakTheBias

Happy #InternationalWomensDay2022! A day to celebrate and highlight the achievements of women in all aspects of life, we're marking the day by sharing some quotes from some of the amazing women working within @eavi2020 👏 #IWD2022 #BreakTheBias 🙅‍♀️

We are looking for healthy volunteers to take part in our COVID-19 vaccine study. If you’re aged 30-55 and in good health contact the recruitment team by emailing flu-rsv-study@imperial.ac.uk to find out more. You will be compensated up to £1010 for your time and inconvenience.

9/What’s next for COVAC1? In our next paper we will examine how the COVID-19 SARNA vaccine fares when given to more people with a bigger age range and with a longer gap between doses.

8/Where next for SARNA? Theoretically a low dose vaccine platform would have fewer side effects, scalability and the potential for multivalent products like flu vaccine. Realising this with a formulation that is immunogenic at low dose levels is the goal of next gen SARNA.

1/The initial paper from our trial of a self-amplifying RNA (SARNA) COVID-19 vaccine is out now. This is a first SARNA vaccine report in humans; what did we discover? @ImperialInfect @ImperialNHS @MRCCTU @robin_shattock @Dr_HMCheeseman